- Home
- AIG vs EW Comparison
AIG vs EW Comparison
Compare AIG & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIG
- EW
- Stock Information
- Founded
- AIG 1919
- EW 1958
- Country
- AIG United States
- EW United States
- Employees
- AIG N/A
- EW N/A
- Industry
- AIG Life Insurance
- EW Industrial Specialties
- Sector
- AIG Finance
- EW Health Care
- Exchange
- AIG Nasdaq
- EW Nasdaq
- Market Cap
- AIG 44.2B
- EW 42.5B
- IPO Year
- AIG N/A
- EW 2000
- Fundamental
- Price
- AIG $76.67
- EW $73.50
- Analyst Decision
- AIG Buy
- EW Buy
- Analyst Count
- AIG 15
- EW 21
- Target Price
- AIG $83.53
- EW $79.95
- AVG Volume (30 Days)
- AIG 3.9M
- EW 4.3M
- Earning Date
- AIG 02-11-2025
- EW 02-11-2025
- Dividend Yield
- AIG 2.09%
- EW N/A
- EPS Growth
- AIG N/A
- EW 202.97
- EPS
- AIG N/A
- EW 6.97
- Revenue
- AIG $27,027,000,000.00
- EW $5,439,500,000.00
- Revenue This Year
- AIG N/A
- EW $10.34
- Revenue Next Year
- AIG $4.05
- EW $10.65
- P/E Ratio
- AIG N/A
- EW $10.52
- Revenue Growth
- AIG N/A
- EW N/A
- 52 Week Low
- AIG $69.00
- EW $58.93
- 52 Week High
- AIG $80.83
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- AIG 59.27
- EW 54.14
- Support Level
- AIG $73.81
- EW $70.10
- Resistance Level
- AIG $77.25
- EW $76.73
- Average True Range (ATR)
- AIG 1.65
- EW 1.24
- MACD
- AIG 0.13
- EW 0.30
- Stochastic Oscillator
- AIG 81.29
- EW 56.94
About AIG American International Group Inc. New
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a majority stake.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.